Impact of postoperative drainage autologous blood re-transfusion on the coagulation parameters and D-dimer levels of patients after total hip arthroplasty

Transfusion and Apheresis Science

Volumn 55, Issue 1, 2016, Pages 109-113

  Luo, Cheng ^a,b   Luo, Xiangping ^a   He, Yingyi ^b   Li, Jiewen ^b   Huang, Bingsheng ^b   Lin, Lijun ^a   Li, Qi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Panyu Central Hospital   (China)

Author keywords

Coagulation parameters; D dimer; Drainage autologous blood re transfusion; Total hip arthroplasty

Indexed keywords

D DIMER; FIBRINOGEN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING; BLOOD CONSERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SURGICAL DRAINAGE; THROMBOCYTE COUNT; TOTAL HIP PROSTHESIS; VACUUM; HIP REPLACEMENT; METABOLISM; MIDDLE AGED; POSTOPERATIVE CARE;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD COAGULATION; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE;

EID: 84963963836     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.04.001     Document Type: Article

References (21)

1. [1] Nakai, S., Yoshizawa, H., Kobayashi, S., Role of autologous blood transfusion in sacral tumor resection: patient selection and recovery after surgery and blood donation. J Orthop Sci 5:04 (2000), 321–327.
2. [2] Haynes, S.L., Wong, J.C., Torella, F., Dalrymple, K., Pilsworth, L., McCollum, C.N., The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery. Eur J Vasc Endovasc Surg 22:3 (2001), 244–250.
3. [3] Nozoe, T., Miyazaki, M., Saeki, H., Ohga, T., Sugimachi, K., Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma. Cancer 92:7 (2001), 1613–1618.
4. [4] Borgen, P.O., Dahl, O.E., Reikeras, O., Biomarkers of coagulation and fibrinolysis during cemented total hip arthroplasty with pre-versus postoperative start of thromboprophylaxis. Thrombosis, 2013, 2013 563217.
5. [5] Crescibene, A., Martire, F., Gigliotti, P., Rende, A., Candela, M., Postoperative autologous reinfusion in total knee replacement. J Blood Transfus, 2015, 2015 826790.
6. [6] Athanasoulias, V., Mavrogenis, A.F., Sdrenias, C.V., Mitsiokapa, E.A., Lourikas, V., Papagelopoulos, P.J., et al. Post-operative blood salvage and retransfusion in total hip and knee arthroplasty. J Int Med Res 35 (2007), 268–275.
7. [7] Yoo, M.J., Park, H.G., Ryu, J.W., Kim, J.S., The efficacy and safety of autologous transfusion in unilateral total knee arthroplasty. Knee Surg Relat Res 27:3 (2015), 168–172.
8. [8] Levent, A., Eser, K., Kamil, C.K., Fidan, F., Ergan, V., Fidan, H., Effect of shed blood retransfusion on pulmonary perfusion after total knee arthroplasty: a prospective controlled study. Int Orthop 31 (2007), 837–844.
9. [9] Konig, G., Waters, J.H., Washing and filtering of cell-salvaged blood – does it make autotransfusion safer?. Transfus Altern Transfus Med 12:3–4 (2012), 78–87.
10. [10] Liumbruno, G.M., Waters, J.H., Unwashed shed blood: should we transfuse it?. Blood Transfus 9:3 (2011), 241–245.
11. [11] Helwig, U., Sehaub, S., Berghold, A., Ziervogel, H., Coagulation parameters after retransfusion of unwashed blood. J Arthroplasty 21:3 (2006), 385–391.
12. [12] Kearon, C., Natural history of venous thromboembolism. Circulation 107:23 Suppl. 1 (2003), 122–130.
13. [13] Liu, H.W., Kwong, Y.L., Bourke, C., Lam, C.K., Lie, A.K., Wei, D., et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost, 71(4), 1994, 416.
14. [14] Levi, M., van der Poll, T., Schultz, M., New insights into pathways that determine the link between infection and thrombosis. Neth J Med 70:3 (2012), 114–120.
15. [15] Walton, B.L., Byrnes, J.R., Wolberg, A.S., Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost 13:Suppl. 1 (2015), S208–15.
16. [16] Adam, S.S., Key, N.S., Greenberg, C.S., D-dimer antigen: current concepts and future prospects. Blood 113 (2009), 2878–2887.
17. [17] Sugimoto, E., Kuroda, T., Fujita, Y., Namba, Y., Mitani, S., D-dimer testing cannot rule out thromboembolism after major lower extremity arthroplasties and thromboprophylaxis treatment. J Anesth 29:5 (2015), 686–689.
18. [18] Schellong, S.M., Beyer, J., Kakkar, A.K., Halbritter, K., Eriksson, B.I., Turpie, A.G., et al. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost 5:7 (2007), 1431–1437.
19. [19] Qaseem, A., Snow, V., Barry, P., Hornbake, E.R., Rodnick, J.E., Tobolic, T., et al. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 146:6 (2007), 454–458.
20. [20] Lippi, G., Franchini, M., Targher, G., Favaloro, E.J., Help me, doctor! My D-dimer is raised. Ann Med 40:8 (2008), 594–605.
21. [21] Stang, L.J., D-dimer and fibrinogen/fibrin degradation products. Methods Mol Biol 992 (2013), 415–427.